317 related articles for article (PubMed ID: 35237802)
1. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis.
Bayona A; Martínez-Vaello V; Zamora J; Nattero-Chávez L; Luque-Ramírez M; Escobar-Morreale HF
Hum Reprod Update; 2022 Jun; 28(4):501-517. PubMed ID: 35237802
[TBL] [Abstract][Full Text] [Related]
2. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
[TBL] [Abstract][Full Text] [Related]
3. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis.
Skiba MA; Islam RM; Bell RJ; Davis SR
Hum Reprod Update; 2018 Nov; 24(6):694-709. PubMed ID: 30059968
[TBL] [Abstract][Full Text] [Related]
4. Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis.
Escobar-Morreale HF; Roldán-Martín MB
Diabetes Care; 2016 Apr; 39(4):639-48. PubMed ID: 27208367
[TBL] [Abstract][Full Text] [Related]
5. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
Skiba MA; Bell RJ; Herbert D; Garcia AM; Islam RM; Davis SR
Hum Reprod; 2021 May; 36(6):1611-1620. PubMed ID: 33846715
[TBL] [Abstract][Full Text] [Related]
6. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
[TBL] [Abstract][Full Text] [Related]
7. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
[TBL] [Abstract][Full Text] [Related]
8. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
[TBL] [Abstract][Full Text] [Related]
9. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.
Millán-de-Meer M; Luque-Ramírez M; Nattero-Chávez L; Escobar-Morreale HF
Hum Reprod Update; 2023 Nov; 29(6):741-772. PubMed ID: 37353908
[TBL] [Abstract][Full Text] [Related]
10. Hirsutism and Polycystic Ovarian Morphology are the Most Frequent Components of Polycystic Ovary Syndrome in Women with Type 1 Diabetes.
García-Sáenz MR; Lobaton-Ginsberg M; Ramírez-Rentería C; López-Juárez N; Saucedo R; Valencia-Ortega J; Ferreira-Hermosillo A
Arch Med Res; 2023 Nov; 54(7):102895. PubMed ID: 37866088
[TBL] [Abstract][Full Text] [Related]
11. Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus.
Codner E; Escobar-Morreale HF
J Clin Endocrinol Metab; 2007 Apr; 92(4):1209-16. PubMed ID: 17284617
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
Cooney LG; Lee I; Sammel MD; Dokras A
Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
[TBL] [Abstract][Full Text] [Related]
13. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of polycystic ovary syndrome and its clinical and hormonal profile in young females with type 1 diabetes mellitus: experience from a teaching institution of India.
Dominic N; Sharma L; Mohindra N; Dabadghao P
Endocrine; 2023 Nov; 82(2):303-310. PubMed ID: 37615813
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
[TBL] [Abstract][Full Text] [Related]
16. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
[TBL] [Abstract][Full Text] [Related]
18. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
[TBL] [Abstract][Full Text] [Related]
19. Validation of circulating microRNAs miR-142-3p and miR-598-3p in women with polycystic ovary syndrome as potential diagnostic markers.
Insenser M; Quintero A; de Lope S; Álvarez-Blasco F; Martínez-García MÁ; Luque-Ramírez M; Escobar-Morreale HF
Hum Reprod; 2023 May; 38(5):951-960. PubMed ID: 36931262
[TBL] [Abstract][Full Text] [Related]
20. Referral bias in female functional hyperandrogenism and polycystic ovary syndrome.
Luque-Ramírez M; Alpañés M; Sanchón R; Fernández-Durán E; Ortiz-Flores AE; Escobar-Morreale HF
Eur J Endocrinol; 2015 Nov; 173(5):603-10. PubMed ID: 26243032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
